S. Lukas

发表

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors.

Michel Emmanuel, Mohammed A Kashem, Lori Patnaude, 2007, Bioorganic & medicinal chemistry letters.

Catalysis and Function of the p38α·MK2a Signaling Complex

C. Pargellis, B. Werneburg, S. Lukas, 2004 .

The oxidase activity of vascular adhesion protein-1 (VAP-1) is essential for function.

R. Wasti, S. Lukas, G. W. Peet, 2013, American journal of clinical and experimental immunology.

The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of Inflammatory Bowel Disease.

M. Mbow, S. Lukas, L. Patnaude, 2021, American journal of physiology. Gastrointestinal and liver physiology.

3 Modulators Independently of S1P Sphingosine-1-Phosphate Receptor Circulating Monocytes Are Reduced by

S. Lukas, L. Patnaude, A. Slavin, 2013 .

No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation

S. Lukas, L. Patnaude, J. Horan, 2014, Journal of biomolecular screening.

Receptor Down-regulation and Degradation 1 S 1 P Receptor Agonists ( Functional Antagonists ) in 1 No Differences Observed among Multiple Clinical S 1 P

S. Lukas, L. Patnaude, J. Horan, 2013 .

Discovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: a new class of inhibitors of lck kinase.

J. Peterson, N. Moss, S. Lukas, 2002, Journal of medicinal chemistry.

Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase.

J. Peterson, S. Pav, N. Moss, 2003, Journal of medicinal chemistry.

Bioluminescent Method for Assaying Multiple Semicarbazide-Sensitive Amine Oxidase (SSAO) Family Members in Both 96- and 384-Well Formats

S. Lukas, Leslie Martin, G. W. Peet, 2011, Journal of biomolecular screening.

A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo

S. Kauschke, E. Hickey, Andre Broermann, 2014, PloS one.

Carboxymethyl-phenylalanine as a Replacement for Phosphotyrosine in SH2 Domain Binding*

J. Proudfoot, L. Tong, S. Lukas, 1998, The Journal of Biological Chemistry.

Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3

M. Brown, S. Lukas, L. Patnaude, 2013, The Journal of Immunology.

Catalysis and function of the p38 alpha.MK2a signaling complex.

C. Pargellis, B. Werneburg, S. Lukas, 2004, Biochemistry.

Discovery and characterization of a substrate selective p38alpha inhibitor.

C. Pargellis, B. Werneburg, S. Lukas, 2004, Biochemistry.

Interaction between the SH2 domains of ZAP-70 and the tyrosine-based activation motif 1 sequence of the zeta subunit of the T-cell receptor.

S. Lukas, S. Jakes, R. Ingraham, 1997, Archives of biochemistry and biophysics.

Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

J. Proudfoot, L. Tong, E. Hickey, 1999, Journal of medicinal chemistry.